AMERISAFE Stock Forecast, Price & News

AMERISAFE (NASDAQ:AMSF) Frequently Asked Questions

Is AMERISAFE a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AMERISAFE in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AMERISAFE stock.
View analyst ratings for AMERISAFE or view top-rated stocks.

How has AMERISAFE's stock been impacted by Coronavirus (COVID-19)?

AMERISAFE's stock was trading at $60.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMSF stock has decreased by 14.7% and is now trading at $52.02.
View which stocks have been most impacted by COVID-19.

When is AMERISAFE's next earnings date?

AMERISAFE is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for AMERISAFE.

How were AMERISAFE's earnings last quarter?

AMERISAFE, Inc. (NASDAQ:AMSF) issued its quarterly earnings results on Tuesday, October, 26th. The insurance provider reported $1.02 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.77 by $0.25. The insurance provider had revenue of $73.82 million for the quarter, compared to analysts' expectations of $76.42 million. AMERISAFE had a net margin of 27.85% and a trailing twelve-month return on equity of 17.07%. During the same period in the previous year, the company posted $1.16 earnings per share.
View AMERISAFE's earnings history.

How often does AMERISAFE pay dividends? What is the dividend yield for AMERISAFE?

AMERISAFE declared a quarterly dividend on Friday, October 29th. Investors of record on Friday, December 3rd will be given a dividend of $0.29 per share on Friday, December 17th. This represents a $1.16 annualized dividend and a yield of 2.23%. The ex-dividend date of this dividend is Thursday, December 2nd.
View AMERISAFE's dividend history.

Is AMERISAFE a good dividend stock?

AMERISAFE pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.17%. AMERISAFE has been increasing its dividend for 8 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of AMERISAFE is 24.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AMERISAFE will have a dividend payout ratio of 40.70% next year. This indicates that AMERISAFE will be able to sustain or increase its dividend.
View AMERISAFE's dividend history.

What price target have analysts set for AMSF?

1 analysts have issued 12 month price targets for AMERISAFE's shares. Their forecasts range from $70.00 to $70.00. On average, they anticipate AMERISAFE's share price to reach $70.00 in the next twelve months. This suggests a possible upside of 34.6% from the stock's current price.
View analysts' price targets for AMERISAFE or view top-rated stocks among Wall Street analysts.

Who are AMERISAFE's key executives?

AMERISAFE's management team includes the following people:

• Gerry Janelle Frost, President, Chief Executive Officer & Director (LinkedIn Profile)
• Neal Andrew Fuller, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Vincent J. Gagliano, Chief Risk Officer & Executive Vice President (LinkedIn Profile)
• Kathryn Housh Shirley, Secretary, Chief Administrative Officer & EVP
• Andrew Brook McCray, Chief Underwriting Officer & Executive VP (LinkedIn Profile)

What is Janelle Frost's approval rating as AMERISAFE's CEO?

18 employees have rated AMERISAFE CEO Janelle Frost on Glassdoor.com. Janelle Frost has an approval rating of 79% among AMERISAFE's employees.

Who are some of AMERISAFE's key competitors?

Some companies that are related to AMERISAFE include Progressive (PGR), Travelers Companies (TRV), Allstate (ALL), Cincinnati Financial (CINF), Markel (MKL), Arch Capital Group (ACGL), Fidelity National Financial (FNF), W. R. Berkley (WRB), CNA Financial (CNA), First American Financial (FAF), Old Republic International (ORI), RLI (RLI), Selective Insurance Group (SIGI), The Hanover Insurance Group (THG) and AXIS Capital (AXS).
View all of AMSF's competitors.

What other stocks do shareholders of AMERISAFE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AMERISAFE investors own include Rollins (ROL), BioDelivery Sciences International (BDSI), Cronos Group (CRON), Quotient Technology (QUOT), Dominion Energy (D), AT&T (T), Bristol-Myers Squibb (BMY), CenterPoint Energy (CNP), Invesco (IVZ) and Altria Group (MO).

What is AMERISAFE's stock symbol?

AMERISAFE trades on the NASDAQ under the ticker symbol "AMSF."

Who are AMERISAFE's major shareholders?

AMERISAFE's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.00%), Neuberger Berman Group LLC (7.78%), Victory Capital Management Inc. (6.95%), Dimensional Fund Advisors LP (3.23%), Goldman Sachs Group Inc. (2.87%) and Geode Capital Management LLC (1.96%). Company insiders that own AMERISAFE stock include Andrew B Mccray, G Janelle Frost, Kathryn Housh Shirley, Kevin T Hogan, Neal Andrew Fuller, Philip A Garcia, Philip A Garcia, Sean Traynor and Vincent J Gagliano.
View institutional ownership trends for AMERISAFE.

Which major investors are selling AMERISAFE stock?

AMSF stock was sold by a variety of institutional investors in the last quarter, including Eaton Vance Management, New South Capital Management Inc., Neuberger Berman Group LLC, Citadel Advisors LLC, BlackRock Inc., Goldman Sachs Group Inc., Robeco Institutional Asset Management B.V., and Smith Graham & Co. Investment Advisors LP. Company insiders that have sold AMERISAFE company stock in the last year include Andrew B Mccray, G Janelle Frost, Kathryn Housh Shirley, Kevin T Hogan, Neal Andrew Fuller, and Vincent J Gagliano.
View insider buying and selling activity for AMERISAFE or view top insider-selling stocks.

Which major investors are buying AMERISAFE stock?

AMSF stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., M&G Investment Management Ltd., Granite Investment Partners LLC, Morgan Stanley, Raymond James & Associates, Healthcare of Ontario Pension Plan Trust Fund, Aviva PLC, and Two Sigma Advisers LP. Company insiders that have bought AMERISAFE stock in the last two years include Philip A Garcia, and Sean Traynor.
View insider buying and selling activity for AMERISAFE or or view top insider-buying stocks.

How do I buy shares of AMERISAFE?

Shares of AMSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AMERISAFE's stock price today?

One share of AMSF stock can currently be purchased for approximately $52.02.

How much money does AMERISAFE make?

AMERISAFE has a market capitalization of $1.01 billion and generates $339.48 million in revenue each year. The insurance provider earns $86.60 million in net income (profit) each year or $4.68 on an earnings per share basis.

How many employees does AMERISAFE have?

AMERISAFE employs 394 workers across the globe.

When was AMERISAFE founded?

AMERISAFE was founded in 1985.

What is AMERISAFE's official website?

The official website for AMERISAFE is www.amerisafe.com.

Where are AMERISAFE's headquarters?

AMERISAFE is headquartered at 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634.

How can I contact AMERISAFE?

AMERISAFE's mailing address is 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634. The insurance provider can be reached via phone at (337) 463-9052, via email at [email protected], or via fax at 800-450-1091.